Last reviewed · How we verify

Platelet-Rich Plasma and Fibrin Glue

Daryoush Hamidi Alamdari, PhD · Phase 2 active Small molecule

Platelet-Rich Plasma and Fibrin Glue is a Small molecule drug developed by Daryoush Hamidi Alamdari, PhD. It is currently in Phase 2 development.

At a glance

Generic namePlatelet-Rich Plasma and Fibrin Glue
SponsorDaryoush Hamidi Alamdari, PhD
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Platelet-Rich Plasma and Fibrin Glue

What is Platelet-Rich Plasma and Fibrin Glue?

Platelet-Rich Plasma and Fibrin Glue is a Small molecule drug developed by Daryoush Hamidi Alamdari, PhD.

Who makes Platelet-Rich Plasma and Fibrin Glue?

Platelet-Rich Plasma and Fibrin Glue is developed by Daryoush Hamidi Alamdari, PhD (see full Daryoush Hamidi Alamdari, PhD pipeline at /company/daryoush-hamidi-alamdari-phd).

What development phase is Platelet-Rich Plasma and Fibrin Glue in?

Platelet-Rich Plasma and Fibrin Glue is in Phase 2.

Related